Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 cyclopia sequence 7 Neoplasms 7 Prostatic Neoplasms 6 Polycystic Ovary Syndrome 5 Fatigue 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Obesity 3 Neoplasm Metastasis 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neoplasms, Plasma Cell 2 Nausea 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Insulin Resistance 2 Infertility 2 Hyperandrogenism 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1 Vitamin D Deficiency 1 Tobacco Use Cessation 1

Interventions

fludarabine 12 Cyclophosphamide 11 Busulfan 8 Mycophenolic Acid 6 Dexamethasone 6 fludarabine phosphate 5 Whole-Body Irradiation 5 Tacrolimus 5 Melphalan 5 Lenalidomide 5 Granulocyte Colony-Stimulating Factor 4 isatuximab 3 Thiotepa 3 Sirolimus 3 Rituximab 3 Methotrexate 3 Cyclosporine 3 Blood Specimen Collection 3 Alemtuzumab 3 pomalidomide 2 pembrolizumab 2 daratumumab 2 Vorinostat 2 Stem Cell Transplantation 2 Platelet Transfusion 2 Ondansetron 2 Interviews as Topic 2 Filgrastim 2 Exercise 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hematologic Diseases × Sugars × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡